ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 528 filers reported holding ASTRAZENECA PLC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $398,532 | -5.4% | 5,885 | 0.0% | 0.05% | -8.5% |
Q2 2023 | $421,189 | +3.1% | 5,885 | 0.0% | 0.06% | +3.5% |
Q1 2023 | $408,478 | +2.4% | 5,885 | 0.0% | 0.06% | +3.6% |
Q4 2022 | $399,003 | +23.5% | 5,885 | 0.0% | 0.06% | +14.6% |
Q3 2022 | $323,000 | -17.0% | 5,885 | 0.0% | 0.05% | -15.8% |
Q2 2022 | $389,000 | -0.3% | 5,885 | 0.0% | 0.06% | +18.8% |
Q1 2022 | $390,000 | +10.5% | 5,885 | -2.9% | 0.05% | +17.1% |
Q4 2021 | $353,000 | -3.0% | 6,060 | 0.0% | 0.04% | -12.8% |
Q3 2021 | $364,000 | +0.3% | 6,060 | 0.0% | 0.05% | +2.2% |
Q2 2021 | $363,000 | +20.6% | 6,060 | 0.0% | 0.05% | +21.1% |
Q1 2021 | $301,000 | -0.7% | 6,060 | 0.0% | 0.04% | 0.0% |
Q4 2020 | $303,000 | -83.4% | 6,060 | -81.8% | 0.04% | -86.1% |
Q3 2020 | $1,825,000 | +1.0% | 33,310 | -2.5% | 0.27% | -12.7% |
Q2 2020 | $1,807,000 | +28.4% | 34,160 | +8.4% | 0.31% | +18.0% |
Q1 2020 | $1,407,000 | -11.8% | 31,510 | -1.5% | 0.27% | +18.8% |
Q4 2019 | $1,596,000 | +11.9% | 32,000 | 0.0% | 0.22% | +7.7% |
Q3 2019 | $1,426,000 | -24.7% | 32,000 | -30.3% | 0.21% | -20.0% |
Q2 2019 | $1,895,000 | +2.1% | 45,900 | 0.0% | 0.26% | -7.5% |
Q1 2019 | $1,856,000 | -18.3% | 45,900 | -23.2% | 0.28% | -20.6% |
Q4 2018 | $2,271,000 | -4.0% | 59,800 | 0.0% | 0.35% | +8.3% |
Q3 2018 | $2,366,000 | +12.7% | 59,800 | 0.0% | 0.33% | +11.6% |
Q2 2018 | $2,100,000 | +0.4% | 59,800 | 0.0% | 0.29% | -4.2% |
Q1 2018 | $2,091,000 | +0.8% | 59,800 | 0.0% | 0.31% | +1.3% |
Q4 2017 | $2,075,000 | +2.4% | 59,800 | 0.0% | 0.30% | -1.6% |
Q3 2017 | $2,026,000 | +32.7% | 59,800 | +33.5% | 0.31% | +27.9% |
Q2 2017 | $1,527,000 | +5.2% | 44,800 | -3.9% | 0.24% | +8.1% |
Q1 2017 | $1,451,000 | +14.0% | 46,600 | 0.0% | 0.22% | +17.5% |
Q4 2016 | $1,273,000 | -16.9% | 46,600 | 0.0% | 0.19% | -22.5% |
Q3 2016 | $1,531,000 | -51.6% | 46,600 | -55.5% | 0.24% | -54.6% |
Q2 2016 | $3,164,000 | +7.3% | 104,800 | +0.1% | 0.54% | +5.5% |
Q1 2016 | $2,948,000 | -7.4% | 104,700 | +11.6% | 0.51% | -10.2% |
Q4 2015 | $3,185,000 | – | 93,800 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |